Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
出版年份 2019 全文链接
标题
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
作者
关键词
-
出版物
Cancers
Volume 11, Issue 7, Pages 909
出版商
MDPI AG
发表日期
2019-06-28
DOI
10.3390/cancers11070909
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
- (2019) Madhav Prasad Yadav et al. EJNMMI Research
- Genotype-phenotype correlations in pheochromocytoma and paraganglioma
- (2019) Joakim Crona et al. ENDOCRINE-RELATED CANCER
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
- (2018) Ulrike Garske-Román et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours
- (2018) Emre Demirci et al. NUCLEAR MEDICINE COMMUNICATIONS
- Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
- (2018) Grace Kong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
- (2014) Jacques W. M. Lenders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
- (2012) David Taïeb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
- (2009) Mattias Sandström et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine
- (2008) Hui Huang et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
- (2008) Anthony M. Joshua et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now